Results 251 to 260 of about 2,401,395 (295)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Towards an international research agenda for public health advocacy: Practice, preparedness and knowledge gaps. [PDF]

PLOS Glob Public Health
Cullerton K, D'cunha K, Clifford Astbury C, Hunt D, Bhatti AJ, Aryeetey R.   +5 more
europepmc   +1 more source

Clinical governance in radiation oncology. [PDF]

Rep Pract Oncol Radiother
Malicki J, Guedea F, Krengli M.
europepmc   +1 more source

Principles underpinning the organisation of 16 - 19 provision [PDF]

, 2003

core  

From minor loci to major players? Satellite DNA diversification in Crepis sensu stricto. [PDF]

Chromosome Res
Senderowicz M, Borowska-Żuchowska N, Yücel G, Nowak T, Daini G, Kolano B.   +5 more
europepmc   +1 more source

Midwives' Perceptions of Barriers to Implementing Evidence-Based Practice in Northern Jordan. [PDF]

SAGE Open Nurs
Hatamleh R, Al-Akour N, Smadi R, Atout M.   +3 more
europepmc   +1 more source

"The birth of the association of European National Olympic Committees and its stakes during the 1960s to 1970s". [PDF]

Front Sports Act Living
Lefèvre F.
europepmc   +1 more source